Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASY-B2B: Bivalirudin vs Heparin in Transradial PCI
NCT01084993Phase 4Unknown
- Sponsor
- Université Laval
- Start
- Mar 2010
- Primary completion
- Sep 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bivalirudin in coronary artery disease (CAD), sponsored by Université Laval. Status: unknown.
02
Drugs
bivalirudin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01084993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01084993.